Gastric or Duodenal Ulcers: Clinical Trials

4 completed. 1 Phase 1.

By phase and status

Phase	Trials	Status
Phase 1	1	Completed 1

Follow Gastric or Duodenal Ulcers: new trials by email Literature Review of Gastric or Duodenal Ulcers trials Research Report on Gastric or Duodenal Ulcers

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
A Study to Evaluate the Pharmacokinetics and Safety Between Single Administration of "BR6002" and Coadministration of "BR6002A" and "BR6002B" Under Fasting Conditions in Healthy Adult Volunteers BR6002A, BR6002B, BR6002 - Gastric or Duodenal Ulcers	Phase 1	Completed	Boryung Pharmaceutical Co., Ltd	40	2023-07-14	2023-12-05
Special Drug Use Surveillance of Vonoprazan for "Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Low-dose Aspirin: Long-term Use" Vonoprazan - Gastric or Duodenal Ulcers		Completed	Takeda	1119	2016-09-01	2020-03-11
Long-term Use of Takepron on the Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Non-steroidal Anti-inflammatory Drugs Lansoprazole - Gastric or Duodenal Ulcers		Completed	Takeda	3502	2010-10-01	2016-10-27
Long-term Use of Takepron Capsules on the Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Low-dose Aspirin Lansoprazole - Gastric or Duodenal Ulcers		Completed	Takeda	3366	2010-08-01	2016-11-04

Narrower conditions

Duodenal Ulcer (4)

Broader conditions

Digestive System Diseases (4)  ·  Duodenal Diseases (4)  ·  Gastrointestinal Diseases (4)  ·  Intestinal Diseases (4)  ·  Peptic Ulcer (4)  ·  Stomach Diseases (4)

Interventions

Lansoprazole (2)  ·  1-(5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine (1)  ·  Tablets (1)

Sponsors

Takeda (3)  ·  Boryung Pharmaceutical Co., Ltd (1)

Countries

Japan (1)  ·  South Korea (1)